Physician profile
Heath A Fallin
NPI 1710137815
$3,439.05
in general payments reported to CMS, 2019-2025
13 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $339 · 2021: $288 · 2022: $291 · 2023: $381 · 2024: $1,625 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,179 · Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,178.74 |
| Food and Beverage | $1,038.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,855.93 | 2019-2025 | Proclaim, Eterna, Octrode |
| Curonix LLC | $1,326.48 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $88.38 | 2023-2024 | |
| Medtronic, INC. | $36.57 | 2025 | Inceptiv |
| Tersera Therapeutics LLC | $22.31 | 2021 | |
| Globus Medical, INC. | $20.93 | 2025 | Senza |
| Greenwich Biosciences, INC. | $18.67 | 2019 | |
| Vertos Medical, INC. | $13.45 | 2020 | |
| Biogen, INC. | $12.67 | 2019 | |
| Sentynl Therapeutics, INC. | $12.04 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.32 | 2020 | |
| Merck Sharp & Dohme LLC | $11.01 | 2019 | |
| Spr Therapeutics, INC | $9.29 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heath Fallin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.